Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1305-1315

  Lin, Henry J ^a   Lakkides, Karen M ^b   Keku, Temitope O ^c   Reddy, Srinivasa T ^c   Louie, Andrew D ^a   Kau, Irving H ^a   Zhou, Haiyan ^a   Gim, Jason S Y ^a   Ma, Hoang L ^a   Matthies, Carl F ^a   Dai, Aihua ^a   Huang, Hsiao Fen ^a   Materi, Alicia M ^a   Lin, Jesse H ^f   Frankl, Harold D ^g   Lee, Eric R ^h   Hardy, Steven I ^c   Herschman, Harvey R ^d   Henderson, Brian E ^f   Kolonel, Laurence N ^e   Le Marchand, Loïc ^e   Garavito, R Michael ^b   Sandier, Robert S ^c   Haile, Robert W ^f   Smith, William L ^b   more..

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Michigan State University   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g KAISER PERMANENTE   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE; CYCLOOXYGENASE 2; PROSTAGLANDIN SYNTHASE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; CHINESE; COLON ADENOMA; COLORECTAL CANCER; ENZYME ACTIVE SITE; ETHNIC GROUP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; NEGRO; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOSTABILITY;

ADENOMA; ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CODON; COHORT STUDIES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; HETERODUPLEX ANALYSIS; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN; TRANSFECTION;

EID: 0036847568     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New. Biol., 231: 232-235, 1971
2. Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., and Vane, J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA, 90: 11693-11697, 1994
3. Yokoyama, C., and Tanabe, T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem. Biophys. Res. Commun., 165: 888-894, 1989
4. Kosaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E., and Tanabe, T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem., 221: 889-897, 1994
5. Samuelsson, B., Granström, E., and Hamberg, M. On the mechanism of the biosynthesis of prostaglandins. In: S. Bergström and B. Samuelsson (eds.), Nobel Symposium 2, Prostaglandins pp. 31-44. Stockholm: Almqvist & Wiksell, 1967
6. Hemler, M., Lands, W. E. M., and Smith, W. L. Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme. J. Biol. Chem., 251: 5575-5579, 1976
7. Miyamoto, T., Ogino, N., Yamamoto, S., and Hayalshi, O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem., 251: 2629-2636, 1976
8. Xie, W., Chipman, J. G., Robertson, D. L., Erikson, R. L., and Simmons, D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA, 88: 2692-2696, 1991
9. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., and Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266: 12866-12872, 1991
10. O'Banion, M. K., Sadowski, H. B., Winn, V., and Young, D. A. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol. Chem., 266: 23261-23267, 1991
11. Spencer, A. G., Woods, J. W., Arakawa, T., Singer, I. I., and Smith, W. L. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J. Biol. Chem., 273: 9886-9893, 1998
12. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocaminomas. Gastroenterology, 107: 1183-1188, 1994
13. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995
14. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995
15. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996
16. Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., Taketo, M. M., and Sugihara, K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res., 58: 4823-4826, 1998
17. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-309, 1996
18. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998
19. Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G., and Lubet, R. A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis. Cancer Res., 60: 5040-5044, 2000
20. Jänne, P. A., and Mayer, R. J. Chemoprevention of colorectal cancer. N. Engl. J. Med., 342: 1960-1968, 2000
21. Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L-K., and Levin, B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342: 1946-1952, 2000
22. Kune, G. A., Kune, S., Watson, L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48: 4399-4404, 1988
23. Sandler, R. S., Galanko, J. C., Murray, S. C., Helm, J. F., and Woosley, J. T. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology, 114: 441-447, 1998
24. Min/+. Msh2-/- mice. Cancer Res., 61: 7060-7064, 2001
25. Ganguly, A., Rock, M. J., and Prockop, D. J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl. Acad. Sci. USA, 90: 10325-10329, 1993
26. Williams, C. J., Rock, M., Considine, E., McCarron, S., Gow, P., Ladda, R., McLain, D., Michels, V. M., Murphy, W., Prockop, D. J., and Ganguly, A. Three new point mutations in type II procollagen (COL2A1) and identification of a fourth family with the COL2A1 Arg519→Cys base substitution using conformation sensitive gel electrophoresis. Hum. Mol. Genet., 4: 309-312, 1995
27. Lin, H. J., Probst-Hensch, N. M., Hughes, N. C., Sakamoto, G. T., Louie, A. D., Kau, I. H., Lin, B. K., Lee, D. B., Lin, J., Frankl, H., D., Lee, E. R., Hardy, S., Grant, D. M., and Haile, R. W. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics, 8: 269-281, 1998
28. Laneuville, O., Breuer, D. K., DeWitt, D. L., Hla, T., Funk, C. D., and Smith, W. L. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-Inflammatory drugs. J. Pharmacol. Exp. Ther., 271: 927-934, 1994
29. Lecomte, M., Laneuville, O., Ji, C., DeWitt, D. L., and Smith, W. L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem., 269: 13207-13215, 1994
30. Shimokawa, T., and Smith, W. L. Prostaglandin endoperoxide synthase. The aspirin acetylation region. J. Biol. Chem., 267: 12387-12392, 1992
31. Evans, S. V. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics, 11: 134-138, 127-128, 1993
32. Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., and Browner, M. F. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat. Struct. Biol., 3: 927-933, 1996
33. Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus D., Miyashiro, J. M., Penning, T. D. Selbert K., Isakson, P. C., and Stalling, W. C. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature (Lond.), 384: 644-648, 1996
34. Nicholls, A., Sharp, K. A., and Honig, B. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet., 11: 281-296, 1991
35. Haile, R. W., Witte, J. S., Longnecker, M. P., Probst-Hensch, N., Chen, M-J., Harper, J., Frankl, H. D., and Lee, E. R. A sigmoidoscopy-based case-control study of polyps: Macronutrients, fiber and meat consumption. Int. J. Cancer, 73: 497-502, 1997
36. Kolonel, L. N., Henderson, B. E., Hankin, J. H., Nomura, A. M. Y., Wilkens, L. R., Pike, M. C., Stram, D. O., Monroe, K. R., Earle, M. E., and Nagamine, F. S. A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics. Am. J. Epidemiol., 151: 346-357, 2000
37. Shaw, G., and Kamen, R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46 659-667, 1986
38. Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem., 275: 11750-11757, 2000
39. 2 synthase-1. Nature (Lond.), 367: 243-249, 1994
40. Malkowski, M. G., Ginell, S. L., Smith, W. L., and Garavito, R. M. The productive conformation of arachidonic acid bound to prostaglandin synthase. Science (Wash. DC), 289: 1933-1937, 2000
41. Thuresson, E. D., Lakkides, K. M., Rieke, C. J., Sun, Y., Wingerd, B. A., Micielli, R., Mulichak, A. M., Malkowski, M. G., Garavito, R. M., and Smith, W. L. Prostaglandin endoperoxide H synthase-1. The functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid. J. Biol. Chem., 276: 10347-10359, 2001
42. Fritsche, E., Baek, S. J., King, L. M., Zeldin, D. C., Eling, T. E., and Bell, D. A. Functional characterization of cyclooxygenase-2 polymorphisms. J. Pharmacol. Exp. Ther., 299: 468-476, 2001
43. Saunders, M. A., Sansores-Garcia, L., Gilroy, D. W., and Wu, K. K. Selective suppression of CCAAT/enhancer-binding protein β binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. J. Biol. Chem., 276: 18897-18904, 2001
44. Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Legarde, M., DeWitt, D. L., and Smith, W. L. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. J. Biol. Chem., 270: 19330-19336, 1995
45. Reddy, S. T., and Herschman, H. R. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem., 269: 15473-15480, 1994
46. 2 and distal prostaglandin synthase I. J. Biol. Chem., 271: 186-191, 1996
47. Swinney, D. C., Mak, A. Y., Barnett, J., and Ramesha, C. S. Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid. J. Biol. Chem., 272: 12393-12398, 1997
48. Thuresson, E. D., Lakkides, K. M., and Smith, W. L. Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. J. Biol. Chem., 275: 8501-8507, 2000
49. Thuresson, E. D., Malkowski, M. G., Lakkides, K. M., Rieke, C. J., Mulichak, A. M., Ginell, S. L., Garavito, R. M., and Smith, W. L. Mutational and x-ray crystallographic analysis of the interaction of dihomo-γ-linolenic acid with prostaglandin endoperoxide H synthases. J. Biol. Chem., 276: 10358-10365, 2001
50. Malkowski, M. G., Thuresson, E. D., Lakkides, K. M., Rieke, C. J., Micielli, R., Smith, W. L., and Garavito, M. R. Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J. Biol. Chem., 276: 37547-37555, 2001
51. Wiesner, G. L., Platzer, P., Buxbaum, S., Lewis, S., MacMillen, M., Olechnowicz, J., Willis, J., Chakravarti, A., Elston, R. C., and Markowitz, S. D. Testing for colon neoplasia susceptibility variants at the human COX2 locus. J. Natl. Cancer Inst., 93: 635-639, 2001
52. Prescott, S. M., and White, R. L. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell. 87: 783-786, 1996
53. Δ716 knockout mice. Nat. Med., 7: 1048-1051, 2001
54. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., and Lehmann, J. M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA, 94: 4318-4323, 1997
55. 2 is a ligand for the adipocyte determination factor PPARγ. Cell, 83: 803-812, 1995
56. 2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res., 59: 2739-2746, 1999
57. Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A-M., Saladin, R., Najib, J., Laville, M., Fruchart, J-C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., and Auwerx, J. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat. Med., 4: 1058-1061, 1998
58. Gimun, G. D., Smith, W. M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Rosenberg, D. W., Bronson, R. T., Edelmann, W., Kucherlapati, R., Gonzalez, F. J., Spiegelman. B. M. APC-dependent suppression of colon carcinogenesis by PPARγ. Proc. Natl. Acad. Sci. USA, 99: 13771-13776, 2002
59. Min-induced tumorigenesis. Proc. Natl. Acad. Sci. USA, 98: 3935-3939, 2001
60. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and Dubois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998
61. Ramsay, R. G., Friend, A., Vizantios, Y., Freeman, R., Sicurella, C., Hammett, F., Armes, J., and Venter, D. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB. Cancer Res., 60: 1805-1809, 2000
62. Imperiale, T. F., Wagner, D. R., Lin, C. Y., Larkin, G. N., Rogge, J. D., and Ransohoff, D. F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N. Engl. J. Med., 343: 169-174, 2000
63. Foutch, P. G., Mai, H., Pardy, K., DiSario, J. A., Manne, R. K., and Kerr, D. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men. Dig. Dis. Sci., 36: 924-928, 1991
64. Antonarakis, S. E., and the Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum. Mut., 11: 1-3, 1998